Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

被引：0
|
作者：
Geeta Hampson
机构：
[1] Guy’s and St Thomas’ NHS Foundation Trust,Department of Chemical Pathology/Metabolic Bone Clinic
来源：
Calcified Tissue International | 2011年 / 88卷
关键词：
Osteoporosis; Bone Formation; Bisphosphonates; Teriparatide; Postmenopausal Osteoporosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Changes in serum fibroblast growth factor 2 in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1–34)
    Marja Hurley
    Wei Yao
    Nancy E. Lane
    Osteoporosis International, 2005, 16 : 2080 - 2084
  • [32] Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels
    Knab, Vanessa M.
    Corbin, Braden
    Andrukhova, Olena
    Hum, Julia M.
    Ni, Pu
    Rabadi, Seham
    Maeda, Akira
    White, Kenneth E.
    Erben, Reinhold G.
    Juppner, Harald
    Christov, Marta
    ENDOCRINOLOGY, 2017, 158 (05) : 1130 - 1139
  • [33] Alterations in vitamin D metabolite, parathyroid hormone and fibroblast growth factor-23 concentrations in sclerostin-deficient mice permit the maintenance of a high bone mass
    Ryan, Zachary C.
    Craig, Theodore A.
    McGee-Lawrence, Meghan
    Westendorf, Jennifer J.
    Kumar, Rajiv
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2015, 148 : 225 - 231
  • [34] Convergent Signaling Pathways Regulate Parathyroid Hormone and Fibroblast Growth Factor-23 Action on NPT2A-mediated Phosphate Transport
    Sneddon, W. Bruce
    Ruiz, Giovanni W.
    Gallo, Luciana I.
    Xiao, Kunhong
    Zhang, Qiangmin
    Rbaibi, Youssef
    Weisz, Ora A.
    Apodaca, Gerard L.
    Friedman, Peter A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (36) : 18632 - 18642
  • [35] Changes in serum fibroblast growth factor 2 in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34)
    Hurley, M
    Yao, W
    Lane, NE
    OSTEOPOROSIS INTERNATIONAL, 2005, 16 (12) : 2080 - 2084
  • [36] Role of fibroblast growth factor 2 and wnt signaling in anabolic effects of parathyroid hormone on bone formation
    Fei, Yurong
    Hurley, Marja M.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (11) : 3539 - 3545
  • [37] Monitoring early developed low bone mineral density in HIV-infected patients by intact parathyroid hormone and circulating fibroblast growth factor 23
    Chen, Kuan-Yu
    Wang, Ching-Hsun
    Lin, Te-Yu
    Chang, Chan-Yuan
    Liu, Chang-Lin
    Hsiao, Yu-Chun
    Hung, Ching-Ching
    Wang, Ning-Chi
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 52 (05) : 693 - 699
  • [38] GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease
    Canney, Mark
    Djurdjev, Ognjenka
    Tang, Mila
    Zierold, Claudia
    Blocki, Frank
    Wolf, Myles
    Levin, Adeera
    AMERICAN JOURNAL OF NEPHROLOGY, 2019, 50 (02) : 105 - 114
  • [39] Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation
    Tomida, Kodo
    Hamano, Takayuki
    Ichimaru, Naotsugu
    Fujii, Naohiko
    Matsui, Isao
    Nonomura, Norio
    Tsubakihara, Yoshiharu
    Rakugi, Hiromi
    Takahara, Shiro
    Isaka, Yoshitaka
    BONE, 2012, 51 (04) : 729 - 736
  • [40] HUMAN PARATHYROID HORMONE(1-34) INCREASES BONE-FORMATION AND STRENGTH OF CORTICAL BONE IN AGED RATS
    EJERSTED, C
    ANDREASSEN, TT
    NILSSON, MHL
    OXLUND, H
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 130 (02) : 201 - 207
12345